Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE-/- mice

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 427-432

  Hamilton, J R ^a,b   Cornelissen, I ^b   Mountford, J K ^a   Coughlin, S R ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Platelets; Protease activated receptor; Thrombin

Indexed keywords

APOLIPOPROTEIN E; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; LIPID DIET; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; THROMBOCYTE ACTIVATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PLATELETS; CROSSES, GENETIC; FEMALE; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PLATELET ACTIVATION; RECEPTORS, THROMBIN; THROMBIN; TIME FACTORS;

EID: 67650901999     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.018     Document Type: Article

References (29)

1. Huo Y., and Ley K.F. Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med 14 (2004) 18-22
2. Harker L.A., Ross R., and Glomset J. Role of the platelet in atherogenesis. Ann N Y Acad Sci 275 (1976) 321-329
3. Ross R., Glomset J., and Harker L. Response to injury and atherogenesis. Am J Pathol 86 (1977) 675-684
4. Peters W., and Charo I.F. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Curr Opin Lipidol 12 (2001) 175-180
5. Massberg S., Brand K., Gruner S., et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196 (2002) 887-896
6. Burger P.C., and Wagner D.D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101 (2003) 2661-2666
7. Massberg S., Schurzinger K., Lorenz M., et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112 (2005) 1180-1188
8. Sachais B.S., Turrentine T., Dawicki McKenna J.M., Rux A.H., Rader D., and Kowalska M.A. Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost 98 (2007) 1108-1113
9. Brand K., Banka C.L., Mackman N., Terkeltaub R.A., Fan S.T., and Curtiss L.K. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. Arterioscler Thromb 14 (1994) 790-797
10. Sanguigni V., Ferro D., Pignatelli P., et al. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 45 (2005) 35-42
11. Landers S.C., Gupta M., and Lewis J.C. Ultrastructural localization of tissue factor on monocyte-derived macrophages and macrophage foam cells associated with atherosclerotic lesions. Virchows Arch 425 (1994) 49-54
12. Wada H., Kaneko T., Wakita Y., et al. Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages. Int J Cardiol 47 (1994) S21-25
13. Huo Y., Schober A., Forlow S.B., et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9 (2003) 61-67
14. Diacovo T.G., Puri K.D., Warnock R.A., Springer T.A., and von Andrian U.H. Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273 (1996) 252-255
15. Shoji T., Koyama H., Fukumoto S., et al. Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients. J Atheroscler Thromb 12 (2005) 344-352
16. Shoji T., Koyama H., Fukumoto S., et al. Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis. Atherosclerosis 188 (2006) 190-195
17. Furman M.I., Benoit S.E., Barnard M.R., et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31 (1998) 352-358
18. Sambrano G.R., Weiss E.J., Zheng Y.-W., Huang W., and Coughlin S.R. Role of thrombin signaling in platelets in haemostasis and thrombosis. Nature 413 (2001) 74-78
19. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
20. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14 (1994) 133-140
21. Reddick R.L., Zhang S.H., and Maeda N. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Arterioscler Thromb 14 (1994) 141-147
22. Zhang S.H., Reddick R.L., Burkey B., and Maeda N. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 94 (1994) 937-945
23. Tilley R.E., Pedersen B., Pawlinski R., et al. Atherosclerosis in mice is not affected by a reduction in tissue factor expression. Arterioscler Thromb Vasc Biol 26 (2006) 555-562
24. Terasawa Y., Ladha Z., Leonard S.W., et al. Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA 97 (2000) 13830-13834
25. Methia N., Andre P., Denis C.V., Economopoulos M., and Wagner D.D. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 98 (2001) 1424-1428
26. Iwaki T., Sandoval-Cooper M.J., Brechmann M., Ploplis V.A., and Castellino F.J. A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice. Blood 107 (2006) 3883-3891
27. Shivdasani R.A., Rosenblatt M.F., Zucker-Franklin D., et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81 (1995) 695-704
28. Levin J., Peng J.-P., Baker G.R., et al. Pathophysiology of thromboctyopenia and anemia in mice lacking transcription factor NF-E2. Blood 94 (1999) 3037-3047
29. Davies M.J. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94 (1996) 2013-2020